IL1B and inflammatory bowel disease: When BSB was administered 3 days before IBD induction, it significantly (p < 0.01, p < 0.001, n = 6) lowered the IL-1β levels from 273.36 ± 23.63 (No BSB, n = 6) to 103.81 ± 22.85 pg/mL of protein (IBD, BSB group) and from 205.36 ± 44.32 (No BSB, n = 6) to 68.46 ± 7.32 (BSB, n = 6) pg/mg of protein on days 2 and 4 of IBD, respectively.